Author

R. Wakabayashi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Research Focus:protein folding & dynamics· 1 Assay:protein structure· 1 Assay:proteomics· 1

Frequent Co-Authors

M. Goto· 2 shared N. Kamiya· 2 shared H. Saputra· 1 shared K. Hayashi· 1 shared K. Minamihata· 1 shared M. Safaat· 1 shared P. Santoso· 1 shared R. Ariyoshi· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

M. Goto

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Exploring the molecular structure of lipids in the design of artificial lipidated antifungal proteins

H. Saputra, M. Safaat, P. Santoso, R. Wakabayashi, M. Goto, T. Taira, N. Kamiya

This study explores lipid modifications of a chitin-binding domain to enhance antifungal activity, finding that specific lipid lengths improve efficacy against Trichoderma viride without significant cytotoxicity.

bioRxiv · Mar 4, 2024Bioengineering

Engineered Active Zymogen of Microbial Transglutaminase

R. Ariyoshi, T. Matsuzaki, R. Sato, K. Minamihata, K. Hayashi, R. Wakabayashi, M. Goto, N. Kamiya

This paper designs an engineered active zymogen of microbial transglutaminase (EzMTG) that exhibits cross-linking activity without requiring proteolysis, and identifies mutations that balance binding affinity and catalytic activity.

bioRxiv · Oct 9, 2023 · PreprintBiochemistry